TLV: BRIN | Revolutionary Non-Invasive Method for Treating Most Common Brain Disorders

Home » Company Profiles » TLV: BRIN | Revolutionary Non-Invasive Method for Treating Most Common Brain Disorders

In this episode of the Investor Profile Series we talk to Dr. Guy Ezekiel, President and CEO of Israel based Brainsway Ltd. (TLV: BRIN).

Brainsway* has revolutionized brain disorder treatment, with Brainsway Deep TMS therapy, or Deep Transcranial Magnetic Stimulation. With Brainsway Deep TMS, patients can regain wellbeing, calm and happiness in just a few weeks.

Brainsway Deep TMS therapy is effective*, safe and generally well-tolerated* for treatment of patients with severe brain disorders. The system is CE cleared for treating numerous conditions, including autism, Alzheimer’s, bipolar disorder, chronic pain, major depressive disorder, Parkinson’s, schizophrenia (negative symptoms), smoking cessation, post-traumatic stress disorder, multiple sclerosis, obsessive compulsive disorder and stroke rehabilitation.

Brainsway’s TMS therapy is non-invasive, does not generate systemic side effects*, and does not require hospitalization or anesthesia.

Brainsway Deep TMS therapy stimulates the brain using a non-invasive approach based on brief magnetic fields.

A widely tested treatment, Brainsway Deep TMS therapy has been utilized in over 60 clinical trials worldwide. It is based on patents registered by the U.S. National Institutes of Health (NIH) and the company.

To learn more about Brainsway, please visit their website at www.brainsway.com.

Get Alerts for Latest Featured Stocks!
Signup today and receive the newest videos. We will never share or sell your email address.
Author: Mike Elliott

Login

Lost your password?